Media Advisory - Minister Ien highlights investments in affordable housing in Budget 2022
CALGARY, AB, April 12, 2022 /CNW/ - Members of the media are invited to join the Honourable Marci Ien, Minister for Women and Gender Equality and Youth, and Sue Tomney, CEO of YWCA Calgary for an important announcement highlighting Budget 2022's investments in affordable housing.
There will be a media availability at 11:45 a.m. MT.
Date:
Wednesday, April 13, 2022
Time:
11:30 a.m. MT (event start time)
Location:
YWCA Calgary
1715-17 Avenue SE
Calgary, AB
Notes for media:
Members of the media may attend this event in person or via a teleconference line. Those who wish to participate via the teleconference line must register by 10:30 a.m. MT on Wednesday, April 13, 2022, to receive the teleconference line number and passcode to the event.
Those who wish to attend in person are asked to respect provincial public health guidance. Please do not attend the event in person if you are feeling unwell or experiencing any symptoms of COVID-19.
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...
Amgen and AstraZeneca today announced the results of the Phase 2a COURSE trial evaluating Tezspire® (tezepelumab-ekko) in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of baseline blood...
Emmy-winning actor and St. Louis native Jon Hamm took the stage Saturday, May 18, to offer words of wisdom to the newest graduates of Saint Louis University (SLU) during the University's spring commencement in St. Louis. ...
Nearly 900 undergraduates of the Class of 2024 celebrated their send-off from Bentley University in a very different way than their 2020 arrival amid the COVID-19 pandemic. The 105th undergraduate commencement ceremony was marked by maskless smiles,...
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...
